A strain of *Pediococcus lactis* NHB-PaA4 used in liquid fermented feed and its application
By screening and optimizing the culture conditions of Pediococcus lactis NHB-PaA4, the problem of poor antibacterial effect of existing strains has been solved, achieving broad-spectrum inhibition of multiple pathogens and improving animal production performance, which can be applied to liquid fermented feed.
Patent Information
- Application Number
- CN202211079669.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-09-05
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2042-09-05
AI Technical Summary
The existing Pediococcus lactis NHE-Pa11403 has only moderate antibacterial effects against Staphylococcus aureus and Salmonella, and cannot meet the demand for antibiotic alternatives in intensive animal husbandry.
A strain of Pediococcus lactis NHB-PaA4 was provided. By isolating and screening strains with strong acid-producing and antibacterial abilities from naturally fermented foods, and optimizing their culture conditions, Pediococcus lactis NHB-PaA4 was formed. It can widely inhibit a variety of pathogens and can be applied to liquid fermented feed.
Lactococcus lactis NHB-PaA4 significantly inhibits a variety of pathogens, improves the balance of animal intestinal flora, increases feed conversion rate and animal production performance, reduces diarrhea rate, improves animal health and meat quality, and provides highly effective antibacterial and immunoprophylactic effects.
Smart Images

Figure CN116083274B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of microbial fermented feed and liquid feed technology, and particularly relates to a strain of Pietrococcus lactis NHB-PaA4 for use in liquid fermented feed and its application. Background Technology
[0002] With the development of modern society, intensive farming has become the mainstream trend, and the lack of antibiotics often brings huge losses to farmers. However, the long-term overuse of antibiotics has led to increasingly serious problems of bacterial resistance and drug residues. Currently, the feed industry has entered an era of complete "antibiotic ban," so the development of antibiotic alternatives and the research on antibiotic alternative technologies have become important issues in the field of intensive livestock production.
[0003] Probiotics and their metabolites can promote the digestion and absorption of nutrients, enhance basal immunity, inhibit intestinal inflammation, and improve the structure of the intestinal flora. Therefore, probiotic-based microecological preparations have become a major alternative to antibiotics.
[0004] Pediococcus acidilactici, a species of lactic acid coccus, belongs to the genus Pediococcus. It produces acid, regulates the gut microbiota, and maintains intestinal microecological balance. Furthermore, it exhibits antagonistic effects against pathogenic microorganisms in animals, competitively inhibiting them; therefore, it can be used to prepare liquid fermented feed.
[0005] Invention Patent: A strain of *Pediococcus lactis* NHE-Pa11403 and its application, application number 202110810834.9. This invention provides a strain of *Pediococcus lactis* NHE-Pa11403, which can effectively regulate the balance of intestinal microbiota in animals, promote nutrient absorption, improve feed conversion rate, and enhance animal production performance. However, this strain has only moderate antibacterial effects against *Staphylococcus aureus* and *Salmonella*. Therefore, this invention provides a strain of *Pediococcus lactis* with better antibacterial and fermentation effects. Summary of the Invention
[0006] The purpose of this invention is to provide a strain of Pediococcus lactis NHB-PaA4 for use in liquid fermented feed and its application.
[0007] To achieve the above objectives, the present invention provides the following technical solution:
[0008] This invention provides a strain of Pediococcus acidilactici NHB-PaA4, classified and named Pediococcus acidilactici NHB-PaA4, which was deposited on February 28, 2022, at the China General Microbiological Culture Collection Center (CGMCC) with accession number CGMCC NO.24435 and deposit address in Beijing, China.
[0009] Preferably, the *Pediococcus lactis* NHB-PaA4 is a strain of *Pediococcus lactis* isolated from naturally fermented food. It is identified as *Pediococcus lactis* through colony morphology observation and molecular biological identification, and its 16S rDNA sequence is shown in SEQ ID NO. 1.
[0010] Preferably, the *Pediococcus lactis* NHB-PaA4 has the following microbiological characteristics: *Pediococcus lactis* NHB-PaA4 is a Gram-positive coccus that grows well on MRS agar medium. After 48 hours of culture, it forms round colonies with a diameter of 3-4 mm. The colonies are milky white, with a rough, opaque surface, a raised center, and irregular edges. The colony morphology is as follows: Figure 1 Microscopic morphology such as Figure 2 It is Gram-positive, ellipsoidal, non-spore-forming, facultatively anaerobic, with a suitable growth temperature range of 15℃-45℃, an optimal growth temperature of 25℃-37℃, a growth pH of 3.0-7.5, and an optimal pH of 4.0-6.5.
[0011] Preferably, the culture method of the *Pediococcus lactis* NHB-PaA4 is as follows:
[0012] Seed culture of *Pediococcus lactis* NHB-PaA4 (preservation number CGMCC No. 24435) (live bacteria concentration of 10) was taken. 9 15 mL of the CFU / mL seed culture was inoculated into 350 mL of shake-flask fermentation medium for shake-flask fermentation. After shake-flask fermentation, the culture was transferred to a 100 L fermenter. 700 mL of the shake-flask fermentation seed culture was inoculated into the 100 L fermenter for further fermentation. The total volume of the 100 L fermenter was 70 L of fermentation medium. After fermentation, the viable cell count in the fermentation broth was 4.6 × 10⁻⁶. 10 The fermentation broth was stored at 4°C in a refrigerator for later use, with a concentration of CFU / mL.
[0013] The shake flask fermentation medium consists of the following components: glucose 0.5-4%, tryptone 0.5-4%, magnesium sulfate 0.01-0.5%, dipotassium hydrogen phosphate 0.01-0.5%, calcium carbonate 0.01-1.0%, manganese sulfate 0.01-0.1%, Tween-80 0.05-0.5%, and the balance being water.
[0014] The preferred composition is: 1.2% glucose, 2.5% tryptone, 0.2% magnesium sulfate, 0.2% dipotassium hydrogen phosphate, 0.1% calcium carbonate, 0.01% manganese sulfate, 0.05% Tween-80, with the balance being water.
[0015] The shake-flask fermentation conditions are as follows: inoculum size 1-10% (volume ratio), fermentation temperature 20-40℃, initial pH 4.0-6.5, 80-300 r / min, and fermentation time 8-48 h.
[0016] The preferred inoculum size is 1% (volume ratio), fermentation temperature is 32℃, initial pH is 6.5, 180 r / min, and fermentation time is 16 h.
[0017] The culture medium composition of the 100L fermenter is as follows: 0.5-4% edible glucose, 0.2-1.5% lactic acid bacteria nutrients, 0.5-2% tryptone, 0.01-0.5% magnesium sulfate, 0.01-1.0% calcium carbonate, 0.01-0.5% manganese sulfate, and the balance is water.
[0018] The preferred composition is: 2% edible glucose, 1.5% lactic acid bacteria nutrients, 1.5% tryptone, 0.1% magnesium sulfate, 0.1% calcium carbonate, 0.02% manganese sulfate, with the remainder being water.
[0019] The culture conditions for the 100L fermenter are as follows: initial pH 4.0-6.5, culture medium volume of 50-70L, tank pressure of 0.03-0.06MPa, inoculum volume of 700mL-7L, fermentation temperature of 25-40℃, fermentation time of 20-48h, and stirring speed of 80-300r / min.
[0020] The preferred conditions are: initial pH 6.5, controlled pH 5.0, 70L culture medium volume, controlled tank pressure 0.05MPa, inoculum volume 700mL, fermentation temperature 30℃, fermentation time 24h, and stirring speed 300r / min.
[0021] This invention provides the application of Porphyromonas lactis NHB-PaA4 in antibacterial agents.
[0022] Preferably, the antibacterial agent has an antibacterial spectrum including the following bacteria: Erysipelothrix rhusiopathiae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Listeria monocytogenes, Streptococcus pneumoniae, enteropathogenic Escherichia coli, Staphylococcus aureus, Salmonella typhi, Salmonella, Clostridium perfringens, Proteus penebrionis, Aeromonas hydrophila, and Vibrio parahaemolyticus.
[0023] The present invention provides an antimicrobial agent containing Pediococcus lactis, the antimicrobial agent comprising the fermentation broth of Pediococcus lactis NHB-PaA4 and a pharmaceutically acceptable carrier.
[0024] Preferably, the viable count of *Pediococcus lactis* NHB-PaA4 in the fermentation broth is 4.6 × 10⁻⁶. 10 CFU / mL.
[0025] This invention provides the application of Pleurotus ostreatus NHB-PaA4 in the preparation of immunoprophylactic agents for animals infected with Salmonella.
[0026] This invention provides the application of Pietrococcus lactis NHB-PaA4 in the preparation of fermented liquid feed.
[0027] This invention provides the application of Pleurotus ostreatus NHB-PaA4 in the preparation of drugs for the prevention or treatment of diarrhea in animals.
[0028] This invention provides the application of Pleurotus ostreatus NHB-PaA4 in improving feed conversion rate and enhancing animal production performance.
[0029] The beneficial effects of this invention are:
[0030] (1) The *Pediococcus lactis* NHB-PaA4 strain of the present invention has strong acid-producing ability, strong antibacterial ability, and does not degrade lysine during fermentation; after optimization of the fermentation medium and process, the viable count of the fermentation broth can reach 4.6 × 10⁻⁶ after fermentation at 32℃ for 16 hours. 10 With a concentration of CFU / mL, it can be used in the production of liquid fermented feed, laying a solid foundation for future development.
[0031] (2) The lactic acid porphyria NHB-PaA4 of the present invention has significant probiotic properties and can significantly inhibit swine erysipelas, Pseudomonas aeruginosa, Klebsiella pneumoniae, Listeria monocytogenes, Streptococcus pneumoniae, enteropathogenic Escherichia coli, Staphylococcus aureus, Salmonella typhi, Salmonella, Clostridium perfringens, Proteus penicillinus, Aeromonas hydrophila, and Vibrio parahaemolyticus, and has broad-spectrum antibacterial properties.
[0032] (3) The *Pediococcus lactis* NHB-PaA4 in this invention can effectively maintain the balance of intestinal flora in animals, improve intestinal function, and enhance animal production performance. In mouse challenge experiments, the average weight gain of the experimental group was significantly higher than that of the control group (P<0.05); after Salmonella challenge, the mental state and survival rate of the experimental group were significantly higher than those of the negative control group. This indicates that feeding *Pediococcus lactis* NHB-PaA4 bacterial solution can effectively prevent and treat diarrhea in mice, improve the survival rate of mice challenged by pathogens, and promote mouse growth.
[0033] (4) The lactic acid bacteria Pediococcus NHB-PaA4 in this invention can be used to prepare liquid fermented feed. The prepared liquid fermented feed is rich in lactic acid bacteria, the pH value is significantly reduced, free amino acids are not lost before and after fermentation and during the storage of liquid fermented feed, and no harmful components are produced. The prepared liquid fermented feed is stable and rich in beneficial microorganisms.
[0034] (5) The liquid fermented feed prepared by *Pediococcus lactis* NHB-PaA4 of this invention, when applied to weaned piglet production, results in piglets with healthy bodies, glossy coats, relatively longer static time, and less odor in their feces. Compared with the control group, the liquid fermented feed group significantly increased the daily weight gain of piglets, significantly reduced the feed conversion ratio by 0.26, and significantly reduced the diarrhea rate. It promotes the growth and feed conversion rate of weaned piglets, thereby improving pig farming efficiency.
[0035] (6) The liquid fermented feed prepared by *Pediococcus lactis* NHB-PaA4 of this invention was applied to the production of growing-finishing pigs. The feed conversion ratio of the experimental group was significantly lower than that of the control group, decreasing by 0.21, which improved growth performance and feed conversion rate. It also significantly improved the flavor of pork. The flavor of pork in the liquid feed group was significantly better than that in the control group, thus improving the quality of fattening pigs and producing healthy and delicious pork to provide people with high-quality pork. Attached Figure Description
[0036] Figure 1 This is a colony morphology diagram of Pediococcus lactis NHB-PaA4 on MRS medium.
[0037] Figure 2 This is a Gram staining image of the Pediococcus lactis NHB-PaA4 strain. Detailed Implementation
[0038] The embodiments described are provided to better illustrate the present invention, but are not intended to limit the scope of the invention to the embodiments described. Therefore, non-essential improvements and adjustments made to the embodiments by those skilled in the art based on the above description are still within the scope of protection of the present invention.
[0039] Unless otherwise specified, the chemical reagents used in the examples are all commercially available conventional reagents, and the technical means used in the examples are conventional means well known to those skilled in the art.
[0040] Unless otherwise specified, the percentage sign "%" used in this invention refers to the mass percentage; however, the percentage of a solution, unless otherwise specified, refers to the number of grams of solute contained in 100 mL of solution.
[0041] Example 1
[0042] Isolation, screening and identification of Pediococcus lactis NHB-PaA4
[0043] 1. Isolation and purification of lactic acid bacteria
[0044] (1) Bring the collected fresh naturally fermented food back to the laboratory, weigh 10 grams of the sample under sterile conditions, place it in an Erlenmeyer flask containing 90 mL of sterile physiological saline, and shake it at 37°C for 1 hour. Then, use the 10-fold serial dilution method to dilute it to 1 million times, and select three dilutions of 10,000 times, 100,000 times and 1 million times.
[0045] (2) Take 0.1 mL and spread it on a modified MRS agar plate. After spreading the plate, invert it at 37°C for 48 h. Use an inoculation loop to pick up colonies of suspected lactic acid bacteria with obvious calcium dissolution zone and larger than 5 mm and streak them on MRS agar plates for isolation and culture.
[0046] (3) After 48 hours of culture, select colonies with good isolation effect, transfer them to MRS agar slants with an inoculation loop for pure culture, repeat the pure culture three times, and then suspend the bacterial cells in 20% glycerol solution and store them at -80℃ for later use.
[0047] 2. Observation of colony morphology
[0048] Based on the size of the calcium dissolution zone in step 1, strains with strong acid-producing ability were preliminarily screened and identified as lactic acid bacteria, totaling 389 strains. The glycerol tube cultures preserved in step 1 were activated 2-3 times on MRS agar plates, then inoculated into MRS broth medium and cultured at 37℃ with shaking at 180 rpm for 18-20 hours. Clean slides were used for Gram staining and microscopic examination to observe the microscopic morphology of the strains. Gram-positive, non-spore-forming bacteria were selected for future use.
[0049] 3. Preparation of lactic acid bacteria suspension and fermentation broth
[0050] The lactic acid bacteria obtained in step 1 were streaked on MRS agar plates and cultured at 37°C for 48 hours. Single colonies were picked from the plates and placed in 100 mL of MRS liquid medium. The culture was then carried out at 37°C with shaking at 180 rpm for 24 hours to obtain a lactic acid bacteria suspension for later use. The suspension was then further cultured at 37°C with shaking at 180 rpm for 96 hours to obtain a lactic acid bacteria fermentation broth for later use.
[0051] 4. Screening of lactic acid bacteria's acid-producing ability
[0052] The lactic acid bacteria suspension obtained in step 3 was inoculated into MRS liquid medium at an inoculation rate of 1% (volume ratio) and cultured at 37°C for 12 hours. Lactic acid bacteria that reduced the pH of the fermentation broth to below 4.2 after 12 hours were screened out, and a total of 78 lactic acid bacteria strains were obtained.
[0053] 5. Screening of antibacterial lactic acid bacteria
[0054] The concentration of pathogenic bacteria (Erysipelothrix rhusiopathiae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Listeria monocytogenes, Streptococcus pneumoniae, enteropathogenic Escherichia coli, Staphylococcus aureus, Salmonella typhi, Salmonella, Clostridium perfringens, Proteus penicillinus, Aeromonas hydrophila, Vibrio parahaemolyticus) was 10. 9 Add 2 mL of CFU / mL bacterial suspension to 200 mL of sterile pathogenic bacteria culture medium cooled to approximately 45°C. Then, transfer 10 mL of the unsolidified culture medium onto a nutrient agar plate containing a 10 mL bottom plate to prepare several pathogenic bacteria plates. On a clean bench, use sterile forceps to pick up one sterile Oxford cup (a small round tube with an inner diameter of 6 mm, an outer diameter of 8 mm, and a height of 10 mm; the tube can contain 200 μL of liquid, and both ends of the tube should be smooth) from each pathogenic bacteria nutrient agar plate and place it on the plate, ensuring complete contact with the culture medium. After several minutes, transfer 200 μL of the suspected lactic acid bacteria strain's fermentation broth (obtained in step 3) into each Oxford cup and incubate at 37°C for 24 hours. Perform at least three replicates for each strain, observe and measure the size of the inhibition zone, and label the three strains with large inhibition zones as A3, A4, and A5.
[0055] 6. Screening for lysine degradation by lactic acid bacteria
[0056] The lactic acid bacteria suspension obtained in step 3 was inoculated into MRS liquid medium supplemented with 1% lysine at an inoculation rate of 1% (volume ratio). The culture was carried out at 37°C for 24 hours. The free lysine content was measured every 4 hours. The strain A4 that did not degrade lysine during fermentation was selected.
[0057] 7. Identification of strain species
[0058] The morphology and molecular characteristics of strain A4 were performed. Strain A4 grew well on MRS plates, forming round colonies after 48 hours of incubation. The colonies were 3–4 mm in diameter, milky white, with a rough, opaque surface, a raised center, and irregular edges. The colony morphology was as follows: Figure 1 Microscopic morphology such as Figure 2Gram-positive, ellipsoidal, non-spore-forming, facultatively anaerobic, with a suitable growth temperature range of 15℃-45℃, an optimal growth temperature of 25℃-37℃, and a growth pH of 3.0-7.5, with an optimum pH of 4.0-6.5. Genomic DNA was extracted from strain A4 using a bacterial DNA extraction kit. The 16S rDNA gene fragment of strain A4 was sequenced using primers F and R, and the obtained sequence is shown in SEQ ID NO.1. BLAST analysis of the obtained sequence with 16S rDNA sequences in GenBank showed that strain A4 had 99.93% homology with *Pediococcus acidilactici*. Based on the morphological and 16S rDNA characteristics of strain A4, strain A4 was identified as *Pediococcus acidilactici*, and formally designated as NHB-PaA4.
[0059] 8. Preservation of bacterial strains
[0060] The Pediococcus acidilactici NHB-PaA4 strain obtained through isolation, purification, and screening was deposited on February 28, 2022, at the China General Microbiological Culture Collection Center (CGMCC, address: Institute of Microbiology, Chinese Academy of Sciences, No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing, 100101, China), with accession number CGMCC NO.24435, and classified as Pediococcus acidilactici.
[0061] The modified MRS agar medium consisted of: 1.0% peptone, 0.5% sodium acetate, 1.0% beef extract, 2% glucose, 0.5% yeast extract, 0.1% Tween 80, 0.2% K2HPO4, 0.058% MgSO4, 0.2% diammonium citrate, 0.025% MnSO4, 1.8% agar, 1% calcium carbonate, with the remainder being water, and a pH of 7.0 ± 0.2.
[0062] The composition of MRS agar medium is as follows: 1.0% peptone, 0.5% sodium acetate, 1.0% beef extract, 2% glucose, 0.5% yeast extract, 0.1% Tween 80, 0.2% K2HPO4, 0.058% MgSO4, 0.2% diammonium citrate, 0.025% MnSO4, 1.8% agar, with the balance being water, pH 7.0±0.2.
[0063] The composition of MRS broth medium is as follows: 1.0% peptone, 0.5% sodium acetate, 1.0% beef extract, 2% glucose, 0.5% yeast extract, 0.1% Tween 80, 0.2% K2HPO4, 0.058% MgSO4, 0.2% diammonium citrate, 0.025% MnSO4, with the balance being water, pH 7.0±0.2.
[0064] The culture media for pathogenic bacteria were: TSA + 5% defibrinated sheep blood agar for Erysipelothrix rhusiopathiae, Listeria elatior, and Streptococcus pneumoniae.
[0065] Pseudomonas aeruginosa, Klebsiella pneumoniae, enteropathogenic Escherichia coli, Staphylococcus aureus, Salmonella typhi, Salmonella, Proteus penicillinus, and Aeromonas hydrophila were used as nutrient agar medium.
[0066] Vibrio parahaemolyticus was cultured on TCBS medium, and Clostridium perfringens was cultured on tryptone-sulfite-cycloserine agar medium.
[0067] The composition of TSA+5% defibrinated sheep blood agar is: 1.5% tryptone, 0.5% soybean peptone, 0.5% sodium chloride, 1.5% agar, and the balance is water. The pH is 7.2±0.2. When using, add 5% defibrinated sheep blood after cooling to 50°C.
[0068] The nutrient agar medium consisted of: 1% peptone, 0.3% beef extract, 2% agar, 0.5% NaCl, with the remainder being water, and a pH of 7.2 ± 0.2.
[0069] The TCBS agar medium consisted of: 0.5% yeast extract, 1% peptone, 1% sodium thiosulfate, 1% sodium citrate, 0.5% ox bile extract, 0.3% sodium taurocholate, 2% sucrose, 1% sodium chloride, 0.1% ferric citrate, 0.0004% thymol blue, 1.5% agar, and pH 8.6±0.1.
[0070] The composition of tryptone-sulfite-cycloserine agar medium is as follows: 1.5% tryptone, 0.5% soybean peptone, 0.5% yeast extract, 0.1% sodium metabisulfite, 0.1% ferric ammonium citrate, 2% agar, and the balance is water. The pH is 7.6±0.2. When using, add 20ml / 250mL of filtered and sterilized 0.5% D-cycloserine solution after cooling to 50℃.
[0071] Example 2
[0072] Preparation of fermentation broth of Pediococcus lactis NHB-PaA4
[0073] 15 mL of *Pediococcus lactis* NHB-PaA4 (CGMCC No. 24435) seed culture (viable cell concentration of 10⁹ CFU / mL) was inoculated into 350 mL of shake-flask fermentation medium for shake-flask fermentation. After shake-flask fermentation, the culture was transferred to a 100 L fermenter. 700 mL of the shake-flask fermentation seed culture was inoculated into the 100 L fermenter for further fermentation. The total volume of the 100 L fermenter was 70 L of fermentation medium. After fermentation, the viable cell count in the fermentation broth was 4.6 × 10⁹ CFU / mL. 10 The fermentation broth was stored at 4°C in a refrigerator for later use, with a concentration of CFU / mL.
[0074] The shake-flask fermentation medium consists of the following components: 1.2% glucose, 2.5% tryptone, 0.2% magnesium sulfate, 0.2% dipotassium hydrogen phosphate, 0.1% calcium carbonate, 0.01% manganese sulfate, 0.05% Tween-80, and the remainder is water.
[0075] The shake-flask fermentation conditions were: inoculum size 1% (volume ratio), fermentation temperature 32℃, initial pH 6.5, 180 r / min, and fermentation time 16 h.
[0076] The culture medium composition of the 100L fermenter is: 2% edible glucose, 1.5% lactic acid bacteria nutrients, 1.5% tryptone, 0.1% magnesium sulfate, 0.1% calcium carbonate, 0.02% manganese sulfate, and the remainder is water.
[0077] The culture conditions for a 100L fermenter are as follows: initial pH 6.5, controlled pH 5.0, 70L culture medium, controlled tank pressure 0.05MPa, inoculum size 700mL, fermentation temperature 30℃, fermentation time 24h, and stirring speed 300r / min.
[0078] Example 3
[0079] Probiotic Validation of Pediococcus lactis NHB-PaA4
[0080] (1) Take a concentration of 10 for pathogenic bacteria (Erysipelothrix rhusiopathiae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Listeria monocytogenes, Streptococcus pneumoniae, enteropathogenic Escherichia coli, Staphylococcus aureus, Salmonella typhi, Salmonella, Clostridium perfringens, Proteus penicillinus, Aeromonas hydrophila, Vibrio parahaemolyticus). 9 Add 2 mL of CFU / mL bacterial suspension to 200 mL of pathogenic bacteria culture medium that has been sterilized and cooled to about 45°C. Then, take 10 mL of the unsolidified bacterial culture medium and transfer it to a nutrient agar plate with a 10 mL bottom plate to prepare several pathogenic bacteria plates.
[0081] (2) On a clean bench, use sterile forceps to pick up one sterile Oxford cup (a small round tube with an inner diameter of 6 mm, an outer diameter of 8 mm, and a height of 10 mm, into each pathogenic bacteria nutrient agar plate, and add 200 μL of liquid to the tube; both ends of the tube should be smooth) and place it on the plate, ensuring that it is in contact with the culture medium without any gaps. After 10 minutes, add 200 μL of the fermentation broth prepared in Example 2 to each tube, being careful not to let it overflow. Incubate at 37°C for 12 hours, and then measure the diameter of the inhibition zone. Each experiment was repeated in triplicate, and the average value was taken. The results are shown in Table 1.
[0082] The culture media for pathogenic bacteria were as follows: *Erysipelothrix rhusiopathiae*, *Listeria esculenta*, and *Streptococcus pneumoniae* were cultured on TSA+5% defibrinated sheep blood agar; *Pseudomonas aeruginosa*, *Klebsiella pneumoniae*, enteropathogenic *Escherichia coli*, *Staphylococcus aureus*, *Salmonella typhi*, *Salmonella*, *Proteus penicillinus*, and *Aeromonas hydrophila* were cultured on nutrient agar; *Vibrio parahaemolyticus* was cultured on TCBS medium; and *Clostridium perfringens* was cultured on tryptone-sulfite-cycloserine agar medium.
[0083] The composition of TSA+5% defibrinated sheep blood agar is: 1.5% tryptone, 0.5% soybean peptone, 0.5% sodium chloride, 1.5% agar, and the balance is water. The pH is 7.2±0.2. When using, add 5% defibrinated sheep blood after cooling to 50°C.
[0084] The nutrient agar medium consisted of: 1% peptone, 0.3% beef extract, 2% agar, 0.5% NaCl, with the remainder being water, and a pH of 7.2 ± 0.2.
[0085] The composition of TCBS agar medium is as follows: 0.5% yeast extract, 1% peptone, 1% sodium thiosulfate, 1% sodium citrate, 0.5% ox bile powder, 0.3% sodium taurocholate, 2% sucrose, 1% sodium chloride, 0.1% ferric citrate, 0.0004% thymol blue, 1.5% agar, pH 8.6±0.1.
[0086] The composition of tryptone-sulfite-cycloserine agar medium is as follows: 1.5% tryptone, 0.5% soybean peptone, 0.5% yeast extract, 0.1% sodium metabisulfite, 0.1% ferric ammonium citrate, 2% agar, and the balance is water. The pH is 7.6±0.2. When using, add 20ml / 250mL of filtered and sterilized 0.5% D-cycloserine solution after cooling to 50℃.
[0087] Table 1. Antibacterial effect of Pseudococcus lactis NHB-PaA4 against pathogens.
[0088]
[0089]
[0090] The test results show that Porphyromonas lactis NHB-PaA4 has excellent inhibitory effects on a variety of pathogens.
[0091] Example 4: Acute toxicity test of Pediococcus lactis NHB-PaA4
[0092] The safety evaluation of *Pediococcus lactis* was conducted using an acute toxicity test, following the maximum tolerated dose method according to the national standard GB15193.3-2003. Sixty common Kunming mice (half male, half female, 18-20g each) were routinely fed for one week. Then, the mice were administered 0.25g / mL *Pediococcus lactis* NHB-PaA4 bacterial suspension (equivalent to 15000mg / kg body weight) via gavage three times a day for two consecutive weeks. The mice were then observed for signs of poisoning or death.
[0093] During the experiment, the mice were in good spirits and showed no signs of poisoning or death. Therefore, the maximum tolerated dose (MTD) for acute toxicity testing of the strain of this invention is >15000 mg / kg. According to the grading standards, this strain can be determined to be non-toxic and has high safety.
[0094] Example 5
[0095] Mouse challenge test
[0096] Sixty female C57 mice, weighing 11-13g, were selected and fed a standard diet. They were randomly divided into three groups, each treated with a basal diet for 5 days to allow the mice to adapt quickly. The formal experiment began, consisting of two phases. The first phase was a growth performance observation experiment, in which *Pediococcus lactis* fermentation broth was added to the drinking water of the experimental groups at a concentration of 1×10⁻⁶. 7 CFU / mL. The control and negative control groups drank purified water without added Pediococcus lactis for two consecutive weeks. Mice were weighed before and after the experiment, and their growth was observed during the experiment. The average weight gain rate for each group was calculated, and the results are shown in Table 2. In the second stage, the Salmonella challenge experiment was conducted. The negative control and experimental groups were challenged with Salmonella via gavage at a concentration of 10 CFU / mL. 8 The experimental group received 0.5 mL of Salmonella per mouse via gavage, while the control group received 0.5 mL of physiological saline per mouse. The mice's mental state and mortality were observed after challenge. The experimental group continued to receive 1×10⁻⁶ Salmonella bacteria via oral administration after challenge. 7 Fermentation broth of *Pediococcus lactis* NHB-PaA4 at a concentration of CFU / mL was used. The control and negative control groups received normal drinking tap water. During the experiment, mice were housed in separate cages within the same room, under natural light, and with free access to food. The ambient temperature was controlled at 25±2℃, and the humidity at 60%.
[0097] The fermentation broth of *Pediococcus lactis* mentioned above is the fermentation broth prepared in Example 2.
[0098] Following Salmonella infection, daily observations revealed the following symptoms in mice: near-absence of appetite, lethargy, huddling together, dull fur with a ruffled back, and bloodshot eyes. On day 1 post-infection, the negative control group began showing symptoms, with two mice dying; the surviving mice also exhibited symptoms to varying degrees. In the experimental group, one mouse died on day 5; the remaining mice remained lethargic and refused to eat for five days before gradually recovering.
[0099] Table 3 shows the time to death, number of deaths, and survival rate of each group after challenge. The poisoning phenomenon in the experimental group mice was not severe after challenge, indicating that Lactococcus lactis NHB-PaA4 has a certain immune preventive effect against Salmonella infection, effectively reducing the incidence of Salmonella infection in mice, delaying the onset of disease after challenge, and thus effectively improving the survival rate.
[0100] Table 2. Weight gain of mice
[0101] Grouping Average initial weight (g / piece) Average final weight (g / piece) Average growth rate (%) control group 11.25±0.16 22.14±0.78 <![CDATA[96.80 b ]]> negative control group 11.43±0.24 22.42±0.49 <![CDATA[96.15 b ]]> experimental group 11.30±0.14 26.23±0.21 <![CDATA[132.12 a ]]>
[0102] Table 3. Mouse mortality before and after challenge.
[0103]
[0104]
[0105] Example 6
[0106] Liquid fermentation feed preparation
[0107] Five preserved lactic acid bacteria strains were activated 2-3 times on MRS agar plates, then inoculated into MRS broth medium and cultured at 37℃ with shaking at 180 rpm for 24 hours to obtain four lactic acid bacteria seed cultures for later use. The five lactic acid bacteria seed cultures were mixed thoroughly to obtain a bacterial mixture. This mixture was then added to the liquid feed at a 5% inoculum rate, mixed at 200 rpm for 30 minutes, and then placed in a fermentation tank and fermented in a sealed container for 14 hours to obtain a liquid fermented feed containing *Pediococcus lactis* NHB-PaA4. The liquid fermented feed was tested, and the results of relevant indicators before and after fermentation are shown in Table 4. Fermentation significantly reduced the pH value and redox potential of the liquid feed, significantly increased the microbial content, and did not result in nutrient loss.
[0108] Table 4. Detection results of relevant indicators of liquid fermented feed before and after fermentation.
[0109]
[0110]
[0111] The bacterial culture mixture consists of the following components:
[0112] 30% of *Pediococcus lactis* NHB-PaA4 (fermentation broth prepared in Example 2), 20% of *Lactobacillus paracasei* NHB-LpD2 seed culture, 20% of *Lactobacillus plantarum* NHE-LpE5 seed culture, 20% of *Lactobacillus plantarum* NHE-LpE9 seed culture, and 10% of *Lactobacillus plantarum* NHE-LpE15 seed culture.
[0113] Liquid feed consists of the following components: 30% solid feed and the remainder is water.
[0114] The solid feed consists of the following components: 51.43 parts corn (for medium and large pigs), 15 parts wheat, 5 parts wheat germ (grade II), 11.4 parts soybean meal (protein content ≥ 46%), 8.1 parts wheat bran (crude ash ≤ 5.5%), 5 parts wheat middlings (grade II), 1.03 parts limestone, 0.89 parts L-lysine sulfate and its fermentation byproducts (70%), and 0.3 parts dicalcium phosphate (III). 64 parts, sodium chloride (98.5%) 0.41 parts, montmorillonite (95%) 0.4 parts, L-threonine (98.5%) 0.23 parts, Jiaerfu (M-S220D) 0.2 parts, DL-methionine (98.5%) (imported) 0.18 parts, L-tryptophan (98%) 0.04 parts, Jiaerfu (V-S203) 0.03 parts, phytase (high temperature resistant 20000) 0.02 parts.
[0115] Lactobacillus paracasei NHB-LpD2, with accession number CGMCC NO.24436, was deposited at the China General Microbiological Culture Collection Center on February 28, 2022.
[0116] Lactobacillus plantarum NHE-LpE5, with accession number CGMCC NO.24432, was deposited at the China General Microbiological Culture Collection Center on February 28, 2022.
[0117] Lactobacillus plantarum NHE-LpE9, with accession number CGMCC NO.24433, was deposited at the China General Microbiological Culture Collection Center on February 28, 2022.
[0118] Lactobacillus plantarum NHE-LpE15, with accession number CGMCC NO.24434, was deposited at the China General Microbiological Culture Collection Center on February 28, 2022.
[0119] Example 7
[0120] Effects of liquid fermented feed on the growth performance of weaned piglets
[0121] The experiment used Duroc × Landrace × Large White three-way crossbred weaned piglets (half male, half female) of similar parity and weight. Two hundred piglets were weaned at 28 days and randomly divided into two groups (control group and experimental group), with 10 piglets per pen for each treatment. The experiment lasted 43 days and was conducted under identical conditions. The control group was fed a basal diet (according to Chinese pig feeding standards), while the experimental group was fed the liquid fermented feed prepared in Example 6. Before the experiment, the pigpens were thoroughly disinfected. The control group was fed dry feed buckets, while the experimental group was fed a liquid feed maker. Both groups had free access to feed and water. Feed intake and health status were recorded daily, and the pigs' coat shine and fecal condition were observed regularly. Other feeding and management practices were the same. During the experiment, the experimental group piglets were healthier, had shinier coats, spent more time at rest, and had less fecal odor. Compared to the control group, the liquid fermented feed group significantly increased the daily weight gain of the experimental group piglets, significantly reduced the feed conversion ratio by 0.26, and significantly reduced the diarrhea rate. (Table 5)
[0122] Table 5. Effects of liquid fermented feed on the growth performance of weaned piglets
[0123] project control group experimental group Initial weight (kg) 6.41±0.17 6.41±0.10 Final weight (kg) <![CDATA[20.20±1.02 b ]]> <![CDATA[23.85±1.03 a ]]> Average daily weight gain (g / d) <![CDATA[306±23.56 b ]]> <![CDATA[405±42.18 a ]]> Average daily feed intake (kg / d) <![CDATA[563±56.43 b ]]> <![CDATA[638±43.21 a ]]> Meat-to-fat ratio <![CDATA[1.83±0.14 a ]]> <![CDATA[1.57±0.21 b ]]> diarrhea rate <![CDATA[7.14±0.14 A ]]> <![CDATA[0.95±0.01 B ]]>
[0124] Note: Different lowercase letters in the superscript of the same data indicate significant differences (p<0.05), while the same lowercase letter or no letter in the superscript indicates no significant differences (p>0.05).
[0125] Example 8
[0126] The effects of liquid fermented feed on growing-finishing pigs
[0127] Eighty healthy Duroc × Landrace × Large White three-way crossbred commercial fattening pigs, weighing approximately 20 kg, with a consistent male-to-female ratio and similar ages, were randomly divided into two groups (control group and experimental group), with four pens per group and ten pigs per pen. The control group was fed a basal diet (based on Chinese pig feeding standards); the experimental group was fed a liquid fermented feed prepared in Example 6. The experimental pigs were kept in enclosed pens, fed three times daily, with free access to feed and water. The pens were cleaned daily for 80 days. Feeding management and immunization programs were the same as routine pig farm management, with regular disinfection and timely treatment of any sick pigs. The results showed that the feed conversion ratio in the experimental group was significantly lower than that in the control group, decreasing by 0.21, thus improving growth performance (Table 6). The pork flavor results (Table 7) showed that the pork flavor of the liquid feed group was significantly better than that of the control group.
[0128] Table 6. Effects of liquid fermented feed on the growth performance of finishing pigs
[0129] index control group experimental group Initial weight (kg) 22.05±1.21 22.26±1.02 Final weight (kg) <![CDATA[101.34±6.90 b ]]> <![CDATA[117.23±5.74 a ]]> Average daily weight gain (kg / d) <![CDATA[0.99±0.05 b ]]> <![CDATA[1.19±0.03 a ]]> Average daily feed intake (kg / d) <![CDATA[2.38±0.31 b ]]> <![CDATA[2.61±0.29 a ]]> Meat-to-fat ratio <![CDATA[2.40±0.11 b ]]> <![CDATA[2.19±0.39 a ]]>
[0130] Table 7. Effects of liquid fermented feed on the flavor of fattening pork.
[0131] index control group experimental group Aldehydes <![CDATA[226.88±15.54 b ]]> <![CDATA[308.56±14.91 a ]]> alcohols <![CDATA[28.71±2.89 b ]]> <![CDATA[47.84±4.97 a ]]> esters <![CDATA[1.31±0.98 b ]]> <![CDATA[2.42±1.42 a ]]> Acids <![CDATA[61.48±5.70 b ]]> <![CDATA[106.86±10.03 a <!-- 10 -->]]> Ketones <![CDATA[50.55±3.21 b ]]> <![CDATA[92.60±3.49 a ]]> other 9.53±1.99 9.39±4.14 total <![CDATA[378.47±30.31 b ]]> <![CDATA[567.66±38.97 a ]]>
[0132] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit it. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all such modifications or substitutions should be covered within the scope of the claims of the present invention.
Claims
1. A strain of *Pediococcus lactis* NHB-PaA4 was classified and named *Pediococcus lactis*. (Pediococcus acidilactici) NHB-PaA4 was deposited on February 28, 2022, at the China General Microbiological Culture Collection Center (CGMCC) with accession number CGMCC NO.24435 and deposit address in Beijing, China. The lactic acid cocci NHB The 16S rDNA sequence of PaA4 is shown in SEQ ID NO.1; The lactic acid cocci NHB PaA4 does not degrade lysine during fermentation.
2. The application of *Pediococcus lactis* NHB-PaA4 as described in claim 1 in the preparation of antibacterial agents, characterized in that, The antibacterial agent's antibacterial spectrum includes the following bacteria: Erysipelothrix rhusiopathiae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Listeria monocytogenes, Streptococcus pneumoniae, enteropathogenic Escherichia coli, Staphylococcus aureus, Salmonella typhi, Salmonella, Clostridium perfringens, Proteus penebrionis, Aeromonas hydrophila, and Vibrio parahaemolyticus.
3. An antibacterial agent containing Pediococcus lactis, characterized in that, The antimicrobial agent comprises the fermentation broth of *Pediococcus lactis* NHB-PaA4 as described in claim 1 and a pharmaceutically acceptable carrier; the viable count of *Pediococcus lactis* NHB-PaA4 in the fermentation broth is 4.6 × 10⁻⁶. 10 CFU / mL.
4. The application of *Pediococcus lactis* NHB-PaA4 as described in claim 1 in the preparation of an immunoprophylactic agent for animals infected with Salmonella, characterized in that... In the aforementioned immunoprophylactic agent, the viable bacterial concentration of *Pediococcus lactis* NHB-PaA4 is 1 × 10⁻⁶. 7 CFU / mL.
5. The application of Pietrococcus lactis NHB-PaA4 as described in claim 1 in the preparation of fermented liquid feed.
Citation Information
Patent Citations
A strain of Pediococcus lactis NHE-Pa11403 and its application
CN113564072B
Pediococcus acidilactici and application thereof
CN106957810A
Novel pediococcus acidilactici and application thereof
CN107034163A
Pediococcus acidilactici HEW-AP27 and application thereof
CN108504601A
Pediococcus acidilactici NHE-Pa11403 and application thereof
CN113564072A
